Prosecution Insights
Last updated: November 04, 2026

Cho Plus Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Cho Plus Inc. is currently navigating 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are located in 2 distinct art units, which suggests that the company's biological or pharmaceutical innovations span different specialized technical fields. This distribution requires the applicant to manage the specific requirements and prior art landscapes of multiple separate units.

The portfolio's active matters are assigned to distinct examiners. PYLA, EVELYN Y is the busiest examiner, currently overseeing 1 pending office action. With multiple examiners and art units for the pending actions, there is no overlap in the personnel or technical groups reviewing the company's applications. This structure necessitates a highly individualized prosecution strategy for each matter, as the company must address the unique interpretations of different examiners across distinct areas of biotechnology. This decentralized structure suggests a broad research and development focus that requires a versatile legal strategy involving 1 pending action per examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WANG, RUIXUE 1 55.7% +20.1%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18667926 Viral vector packaging cells made from cell hybrids WANG, RUIXUE —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18667926 Viral vector packaging cells made from cell hybrids WANG, RUIXUE —

Top Art Units

Art UnitApps
1672 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18667926 Viral vector packaging cells made from cell hybrids WANG, RUIXUE 1672 §103§112 Final Rejection — Pending May 17, 2024

Managing Cho Plus Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Cho Plus Inc. have?

Cho Plus Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Cho Plus Inc. applications?

Ruixue Wang has the most, with 1 of Cho Plus Inc.'s pending office actions.

What technology area are Cho Plus Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month